Fundraising Fox

Ward Capoen

Investor

Partner at V-Bio Ventures

Ghent, Flemish Region, Belgium

About

Joined V-Bio Ventures in 2016 as Partner. He holds a PhD in molecular biology, researched at VIB/UGent, John Innes Centre and Harvard Medical School, and previously worked as a senior biotech analyst at Candriam Investors Group.

LinkedIn ↗

Experience

  1. V-Bio VenturesPartnercurrent2022 — presentGhent, Flemish Region, Belgium
  2. V-Bio VenturesPrincipal2019 — 2022Gent Area, Belgium
  3. V-Bio VenturesSenior Analyst2016 — 2018Gent Area, Belgium
  4. Step PharmaBoard Membercurrent2025 — present
  5. Sibylla BiotechBoard Membercurrent2022 — present
  6. BIODOL THERAPEUTICSBoard Membercurrent2020 — present
  7. Augustine Theraupeutics - Corteria PharmaceuticalsBoard Observercurrent2017 — present
  8. Augustine TherapeuticsBoard Member2019 — 2025
  9. Corteria PharmaceuticalsBoard Member2021 — 2023
  10. Aphea.Bio - Precirix - Octimet OncologyBoard Observer (past)2017 — 2023
  11. CandriamSenior Biotechnology Analyst2013 — 2016Brussels Area, Belgium
  12. Harvard Medical School - Brigham and Women's HospitalPostdoctoral Research Fellow2010 — 2012Greater Boston Area
  13. John Innes CentreEMBO Postdoctoral Fellow2006 — 2010Norwich, United Kingdom

Education

  1. Vlerick Business SchoolMaster of Business Administration (MBA)2012 — 2013
  2. Ghent UniversityPhD, Biotechnology2002 — 2006

Skills & more

Biotechnology33Molecular Biology27Venture CapitalGenetics19Pharmaceutical Industry3Equity Research2Cell Biology8Biochemistry11Life Sciences3

From Ward's professional profile.

Same school

Also attended Vlerick Business School64

KobeFinance Director at Hummingbird VenturesLucas De FourLegal Manager at Hummingbird VenturesHendrik Van AsbroeckManaging Partner at Astanor VenturesHarry De SmedtIC at AngelwiseHiram ClausInvestment Director at NPM Capital N.V.Hugo de BruinGeneral Partner at Gilde Healthcare

+ 58 more

Also attended Ghent University70

LukasPartner at Hummingbird VenturesRoxanneCompliance Officer at Hummingbird VenturesSriram BalusuAssociate at Ysios CapitalPhilippe de LathuyLegal Counsel at Astanor VenturesJan VorstermansInvestor at AngelwiseNicolas ChristiaenGrowth | Fintech at Angelwise

+ 64 more

Shared employers

Also worked at V-Bio Ventures5

Christina TakkeManaging Partner at V-Bio VenturesWillem BroekaertManaging Partner at V-Bio VenturesShelley MargetsonManaging Partner at V-Bio VenturesKatja RosenkranzPartner at V-Bio VenturesMathias FalcenbergVenture Partner at V-Bio Ventures

Also worked at Step Pharma1

Claus AnderssonGeneral Partner at Sunstone Capital

Also worked at Candriam7

Mohadeseh AbdullahiPartner at Giant Ventures Global LlpLaëtitia NguyenCFO at Anais VenturesTheany BazetInvestor at Global Social Impact InvestmentQuentin StevenartSenior Financial & Sustainability Analyst at Finance.BrusselsSolenne Niedercorn-DesouchesAdvisor at Fabric VenturesLora OrlandoAnalyst at Newion

+ 1 more

Also worked at Harvard Medical School - Brigham and Women's Hospital116

Logan HilleLife Sciences Analyst at CincyTechAnkit GuptaGeneral Partner at Y CombinatorDavid MollerInvestor at Third Rock VenturesJulie YangInvestor at Third Rock VenturesTracy WilliamsInvestor at Third Rock VenturesSamuel ArbesmanVenture Partner at Lux Capital

+ 110 more

Colleagues at V-Bio Ventures

Aurelie Nowack
Principal at V-Bio Ventures
Charles Margarit
Associate at V-Bio Ventures
Christina Takke
Managing Partner at V-Bio Ventures
Dennis Pedri
Analyst at V-Bio Ventures
Dr. Loïc Laplanche
Chief Operating Officer at V-Bio Ventures
Dr. Marie-Laurence Gourlay-Chu
Chief Medical Officer at V-Bio Ventures
Katja Rosenkranz
Partner at V-Bio Ventures
Martin Solleveld
Finance Manager at V-Bio Ventures